Phase I study of camrelizumab in patients with advanced solid tumors

被引：0
|
作者：
Yuxiang Ma
Jiaxin Cao
Yang Zhang
Qianwen Liu
Wenfeng Fang
Yunpeng Yang
Yuanyuan Zhao
Qing Yang
Hongyun Zhao
Li Zhang
机构：
[1] Sun Yat-sen University Cancer Center,Department of Clinical Research
[2] State Key Laboratory of Oncology in South China,Department of Medical Oncology
[3] Collaborative Innovation Center for Cancer Medicine,undefined
[4] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[5] Sun Yat-sen University Cancer Center,undefined
[6] State Key Laboratory of Oncology in South China,undefined
[7] Collaborative Innovation Center for Cancer Medicine,undefined
[8] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[9] Jiangsu Hengrui Medicine Co. Ltd,undefined
来源：
Signal Transduction and Targeted Therapy | / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Christos E. Kyriakopoulos
    Amy M. Braden
    Jill M. Kolesar
    Jens C. Eickhoff
    Howard H. Bailey
    Jennifer Heideman
    Glenn Liu
    Kari B. Wisinski
    Investigational New Drugs, 2017, 35 : 290 - 297
  • [22] A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
    Liu, Lian
    Zhang, Wen
    Li, Wenhua
    Lv, Fangfang
    Xia, Zuguang
    Zhang, Sheng
    Liu, Wen
    Zandvliet, Anthe S.
    Waajen, Sylvia
    Zhang, Li Xin
    Yan, Li
    Li, Jin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [23] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
  • [24] Phase I study of recombinant human endostatin in patients with advanced solid tumors
    Herbst, RS
    Hess, KR
    Tran, HT
    Tseng, JE
    Mullani, NA
    Charnsangavej, C
    Madden, T
    Davis, DW
    McConkey, DJ
    O'Reilly, MS
    Ellis, LM
    Pluda, J
    Hong, WK
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3792 - 3803
  • [25] A phase I study of bortezomib plus irinotecan in patients with advanced solid tumors
    Ryan, David R.
    O'Neil, Bell H.
    Supko, Jeffrey G.
    Lima, Carlo M. Rocha
    Dees, E. Claire
    Appleman, Leonard J.
    Clark, Jeffrey
    Fidias, Phinos
    Orlowski, Robert Z.
    Kashala, Oscar
    Eder, Joseph R.
    Cusack, James C., Jr.
    CANCER, 2006, 107 (11) : 2688 - 2697
  • [26] A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors
    Sweeney, Christopher J.
    Chiorean, E. Gabriela
    Verschraegen, Claire F.
    Lee, Fa Chyi
    Jones, Suzanne
    Royce, Melanie
    Tye, Lesley
    Liau, Katherine F.
    Bello, Akintunde
    Chao, Richard
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4513 - 4520
  • [27] Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors
    Lin, Chia-Chi
    Calvo, Emiliano
    Papadopoulos, Kyriakos P.
    Patnaik, Amita
    Sarantopoulos, John
    Mita, Alain C.
    Preston, Glenn G.
    Mita, Monica M.
    Rodon, Jordi
    Mays, Theresa
    Yeh, I-Tien
    O'Rourke, Pat
    Takimoto, Chris H.
    Dancey, Janet E.
    Chen, Helen
    Tolcher, Anthony W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1065 - 1071
  • [28] Phase I and pharmacokinetic study of docetaxel and irinotecan in patients with advanced solid tumors
    Couteau, C
    Risse, ML
    Ducreux, M
    Lefresne-Soulas, F
    Riva, A
    Lebecq, A
    Ruffié, P
    Rougier, P
    Lokiec, F
    Bruno, R
    Armand, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3545 - 3552
  • [29] A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
    Lian Liu
    Wen Zhang
    Wenhua Li
    Fangfang Lv
    Zuguang Xia
    Sheng Zhang
    Wen Liu
    Anthe S Zandvliet
    Sylvia Waajen
    Li Xin Zhang
    Li Yan
    Jin Li
    Journal of Hematology & Oncology, 6
  • [30] Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors
    Chia-Chi Lin
    Emiliano Calvo
    Kyriakos P. Papadopoulos
    Amita Patnaik
    John Sarantopoulos
    Alain C. Mita
    Glenn G. Preston
    Monica M. Mita
    Jordi Rodon
    Theresa Mays
    I-Tien Yeh
    Pat O’Rourke
    Chris H. Takimoto
    Janet E. Dancey
    Helen Chen
    Anthony W. Tolcher
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 1065 - 1071
12345